Does a high omega-6 to omega-3 (AA:EPA) ratio promote inflammation?

An elevated ratio of omega-6 to omega-3 fatty acids, specifically measured via the arachidonic acid to eicosapentaenoic acid (AA:EPA) ratio, significantly influences the body's inflammatory tone. For a 61-year-old male, managing this ratio is a highly relevant clinical consideration for cardiovascular health, joint integrity, and systemic aging.

Mechanistic explanations

• Enzymatic competition: Arachidonic acid (AA, omega-6) and eicosapentaenoic acid (EPA, omega-3) directly compete for the same cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. When the AA:EPA ratio is high, AA dominates these enzymatic pathways, shifting cellular metabolism toward the production of highly pro-inflammatory 2-series prostaglandins (such as PGE₂) and 4-series leukotrienes (such as LTB₄). These lipid mediators drive vascular permeability and leukocyte chemotaxis.
• Blunted active resolution: The resolution of inflammation is an active, biochemically driven process mediated by specialized pro-resolving mediators (SPMs), including resolvins, protectins, and maresins. A high omega-6 to omega-3 ratio deprives the body of the EPA and DHA precursors needed to synthesize these SPMs. This deficit compromises the active resolution of inflammation, leading to impaired clearance of apoptotic cells (efferocytosis) by macrophages and continued neutrophil infiltration.
• Systemic inflammatory markers: This dual effect—increased production of inflammatory eicosanoids and reduced synthesis of SPMs—prevents the timely termination of the inflammatory response. Mechanistically, this sustained activation promotes upstream signaling cascades that elevate hepatic acute-phase reactants and systemic cytokines, resulting in elevated high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) levels.

Bottom line

• An elevated omega-6:omega-3 and AA:EPA ratio is strongly supported by metabolic chemistry and clinical evidence to favor pro-inflammatory eicosanoid synthesis while actively impairing the body's specialized pro-resolving pathways. Minimizing this ratio through dietary adjustments or targeted omega-3 supplementation supports the active resolution of systemic inflammation.